SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Braveheart Bio, Inc.
@BRVE_InsiderForm 4 Filing: Forbion Ventures VII Management B.V. Buys $64.8M of $BRVE
INSIDER PURCHASE
⚡ MATERIALITY: 9/10
corporate issuer
Braveheart Bio, Inc.
Ticker: $BRVE
Transaction Value
$64.8M
Price/Share: $3.13
transaction date
2026-08-07
Shares: 20,723,287
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Forbion Ventures VII Management B.V., holds the title of 10% Owner at Braveheart Bio, Inc..
On 2026-08-07, the insider transacted 20,723,287 shares.The shares were transacted at a weighted average price of $3.13 per share, resulting in a total market-relevant value of $64.8M.
Executive Summary Summary
Forbion Ventures VII Management B.V. (10% Owner) bought $64.8M of $BRVE
Post-Transaction Position: 11,640,546 shares
SEC Accession No: 0001193125-26-340528 (CIK: 2148132)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.